FNM CORPORATION LTD – Trademark Portfolio

Entity Type: 03

FNM CORPORATION LTD holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NIPPLEAID and PAINACURE. The owner is based in London.

27 Old Gloucester street

London WC1N3AX , GB

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

FNM CORPORATION LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does FNM CORPORATION LTD have?

FNM CORPORATION LTD has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 3 cancelled.

What trademark classes does FNM CORPORATION LTD file in?

FNM CORPORATION LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are FNM CORPORATION LTD's most well-known trademarks?

FNM CORPORATION LTD's registered trademark portfolio includes well-known marks such as NIPPLEAID and PAINACURE. These are among 2 currently registered trademarks in the portfolio.

What is FNM CORPORATION LTD's trademark registration success rate?

FNM CORPORATION LTD has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.